Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 3031-3037

  Kanazawa, Ippei ^a   Yamaguchi, Toru ^a   Yamauchi, Mika ^a   Yamamoto, Masahiro ^a   Kurioka, Soichi ^a   Yano, Shozo ^a   Sugimoto, Toshitsugu ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; COLLAGEN TYPE 1; GLUCOSE; HEMOGLOBIN A1C; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; BONE METABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 68549120751     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2187     Document Type: Article

References (53)

1. Rä kel A, Sheehy O, Rahme E, LeLorier J 2008 Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 34:193-205
2. Ivers RQ, Cumming RG, Mitchell P, Peduto AJ; Blue Mountains Eye Study 2001 Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care 24:1198-1203
3. Vestergaard P 2007 Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes: a meta-analysis. Osteoporos Int 18:427-444
4. Lipscombe LL, Jamal SA, Booth GL, Hawker GA 2007 The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care 30:835-841
5. Strotmeyer ES, Cauley JA, Schwartz AV, Nevitt MC, Resnick HE, Bauer DC, Tylavsky FA, de Rekeneire N, Harris TB, Newman AB 2005 Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med 165:1612-1617
6. Saito M, Fujii K, Mori Y, Marumo K 2006 Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos Int 17:1514-1523
7. Gerdhem P, Isaksson A, Akesson K, Obrant KJ 2005 Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 16:1506-1512
8. Verhaeghe J, Suiker AM, Nyomba BL, Visser WJ, Einhorn TA, Dequeker J, Bouillon R 1989 Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology 124:573-582
9. Li YM, Schilling T, Benisch P, Zeck S, Meissner-Weigl J, Schneider D, Limbert C, Seufert J, Kassem M, Schü tze N, Jakob F, Ebert R 2007 Effects of high glucose on mesenchymal stem cell proliferation and differentiation. Biochem Biophys Res Commun 363:209-215
10. Alikhani M, Alikhani Z, Boyd C, MacLellan CM, Raptis M, Liu R, Pischon N, Trackman PC, Gerstenfeld L, Graves DT 2007 Advanced glycation end products stimulate osteoblast apoptosis via theMAPkinase and cytosolic apoptotic pathways. Bone 40:345-353
11. Brenner RE, Riemenschneider B, Blum W, Mö rike M, Teller WM, Pirsig W, Heinze E 1992 Defective stimulation of proliferation and collagen biosynthesis of human bone cells by serum from diabetic patients. Acta Endocrinol 127:509-514
12. Balint E, Szabo P, Marshall CF, Sprague SM 2001 Glucose-induced inhibition of in vitro bone mineralization. Bone 28:21-28
13. Yamamoto T, Ozono K, Miyauchi A, Kasayama S, Kojima Y, Shima M, Okada S 2001 Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy. Am J Kidney Dis 38:S161-164
14. Ogawa N, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T 2007 The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs. Horm Metab Res 39:871-875
15. Furie B, Furie BC 1990 Molecular basis of vitamin K-dependent γ-carboxylation. Blood 75:1753-1762
16. Shearer MJ 1995 Vitamin K. Lancet 345:229-234
17. Plantalech L, Guillaumont M, Vergnaud P, Leclercq M, Delmas PD 1991 Impairment of γcarboxylation of circulating osteocalcin (bone Gla protein) in elderly women. J Bone Miner Res 6:1211-1216
18. Szulc P, Chapuy MC, Meunier PJ, Delmas PD 1993 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91:1769-1774
19. Szulc P, ArlotM,ChapuyMC,Duboeuf F, Meunier PJ, Delmas PD 1994 Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9:1591-1595
20. Okazaki R, Totsuka Y, Hamano K, Ajima M, Miura M, Hirota Y, Hata K, Fukumoto S, Matsumoto T 1997 Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab 82:2915-2920
21. Rosato MT, Schneider SH, Shapses SA 1998 Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus. Calcif Tissue Int 63:107-111
22. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935
23. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T 2007 Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 8:51
24. Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U, Reseland JE 2004 Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842-849
25. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY 2006 Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through theMAPKsignaling pathway. J Bone Miner Res 21:1648-1656
26. Richards JB, Valdes AM, Burling K, Perks UC, Spector TD 2007 Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab 92:1517-1523
27. Peng XD, Xie H, Zhao Q, Wu XP, Sun ZQ, Liao EY 2008 Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 387:31-35
28. Gregorio F, Cristallini S, Santeusanio F, Filipponi P, Fumelli P 1994 Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? Diabetes Res Clin Pract 23:43-54
29. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K 1997 Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 12:1272-1279
30. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T 2007 Serum insulin-like growth factor-I is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int 18:1675-1681
31. Nishimura J, Arai N, Tohmatsu J 2007 [Measurement of serum undercarboxylated osteocalcin by ECLIA with the "Picolumi ucOC" kit]. Clin Calcium 17:1702-1708 (Japanese)
32. Stein GS, Lian JB 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424-442
33. Hauschka PV, Lian JB, Cole DE, GundbergCM1989 Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69:990-1047
34. Botolin S, McCabe LR 2006 Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99:411-424
35. Sokoll LJ, Booth SL, O'Brien ME, Davidson KW, Tsaioun KI, Sadowski JA 1997 Changes in serum osteocalcin, plasma phylloquinone, and urinary γ-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr 65:779-784
36. Vergnaud P, Garnero P, Meunier PJ, Bréart G, Kamihagi K, Delmas PD 1997 Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol Metab 82:719-724
37. Liu G, Peacock M 1998 Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 62:286-289
38. Zofková I, Hill M, Palicka V 2003 Association between serum undercarboxylated osteocalcin and bone density and/or quality in early postmenopausal women. Nutrition 19:1001-1003
39. +-ATPase expression: potential role of p38 MAP-kinase. J Cell Biochem 87:75-84
40. Verhaeghe J, van Herck E, Visser WJ, Suiker AM, Thomasset M, Einhorn TA, Faierman E, Bouillon R 1990 Bone and mineral metabolism in BB rats with long-term diabetes: decreased bone turnover and osteoporosis. Diabetes 39:477-482
41. Oshima K, Nampei A, Matsuda M, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H, Shimomura I 2005 Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331:520-526
42. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T 2008 Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcif Tissue Int 83:324-331
43. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T 2009 Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol 160:265-273
44. Jü rimäe J, Jü rimäe T 2007 Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women. Osteoporos Int 18:1253-1259
45. Jürimäe J, Jürimäe T 2007 Plasma adiponectin concentration in healty pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic cariables. Am J Physiol Endocrinol Metab 293:E42-E47
46. Oh KW, Lee WY, Rhee EJ, Baek KH, Yoon KH, Kang MI, Yun EJ, Park CY, Ihm SH, Choi MG, Yoo HJ, Park SW 2005 The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 63:131-138
47. Lee NK, Karsenty G 2008 Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 19:161-166
48. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G 2007 Endocrine regulation of energy metabolism by the skeleton. Cell 130:456-469
49. Ferron M, Hinoi E, Karsenty G, Ducy P 2008 Osteocalcin differentially regulates β-cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105:5266-5270
50. Crossno Jr JT, Majka SM, Grazia T, Gill RG, Klemm DJ 2006 Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 116:3220-3228
51. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, Sugimoto T 2009 Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab 94:45-49
52. Fujimoto WY 1996 Overview of non-insulin-dependent diabetes mellitus (NIDDM) in different population groups. Diabet Med 13:S7-S10
53. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T 2002 Genetic cariation in the gene encoding adiponectin in associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes [Erratum (2002) 51:1294] 51:536-540